The photos do appear to be a form of Staphylococcus induced Cellulitis:
This infection could have resulted in a manifestation of cellulitis, which is a bacterial skin infection that affects the deeper layers of the skin and the underlying tissue. Cellulitis caused by staph bacteria often presents with redness, swelling, warmth, and pain.
Focus here is primarily on the Staph Bacterial Infection, and the considerations of alternate treatment for this issue. The Rife Digital Professional V3 can assist in the treatment of Staph Infections, using the Group 3230, comprising of the frequencies:
Staphylococcal Infections: 0.14, 0.3, 0.95, 178.72, 375.17, 477.5, 527, 667, 761.85, 988.9.
A secondary group for consideration is Group 630 Cellulitis:
0.14, 0.49, 0.79, 12.5, 43, 122.5, 262.5, 555.35, 692.5, 819.34
Combining Rife treatment with a Vitamin C Megadose is recommended.
Leading expert on vitamin C, Dr. Thomas Levy states:
“My clinical opinion is that one gram of properly-produced and orally-ingested liposome-encapsulated vitamin C is as good or more effective than 5 to 10 grams of vitamin C given intravenously, for an acute viral syndrome. When someone is ill, my advice is still to use as many forms of vitamin C as available, and dosed as highly as is feasible.”
Suggested oral Vitamin C dosage (Vitamin C tablet form) of 3,000 mg every 4 hours, per daytime period.
An alternate method of Intravenous (IV) vitamin C, involves administering high doses of vitamin C directly into the bloodstream via a vein. This method allows for higher concentrations of vitamin C to be achieved in the body compared to oral supplementation. Injectable vitamin C is often used in clinical settings for various purposes, including supporting immune function, combating oxidative stress, and as an adjunctive therapy in the treatment of certain medical conditions such as the treatment of methicillin-resistant Staphylococcus
I have also summarized the research paper from (NIH-23059632) below for you, so as to illustrate large dose vitamin C treatment for methicillin-resistant Staphylococcus
Ascorbic acid (vitamin C) has the potential to inhibit the growth and biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA). Here are some considerations based on this research:
Inhibition of Biofilm Formation: Biofilms are communities of bacteria encased in a matrix of extracellular polymeric substances. They provide protection to bacteria, making them more resistant to antibiotics and immune defenses. The study found that ascorbic acid reduced biofilm formation by MRSA, which could potentially enhance the effectiveness of antibiotic treatments.
Antibacterial Properties: The research indicates that ascorbic acid exerts antibacterial effects against MRSA, suggesting a potential role in combating staph infections. This finding aligns with the broader understanding of vitamin C’s antimicrobial properties and its ability to support immune function.
Colony Spreading: The study also observed that ascorbic acid augmented colony spreading, which refers to the ability of bacteria to expand across a surface. While this aspect may seem counterintuitive in the context of combating bacterial infections, it’s important to note that colony spreading can influence the behavior of bacterial populations and their interactions with host tissues.
Potential Clinical Applications: The findings of this study suggest that ascorbic acid could be explored as a complementary approach for managing staph infections, particularly those caused by antibiotic-resistant strains like MRSA. In summary, this study suggests that vitamin C may inhibit the growth and biofilm formation of MRSA, highlighting its potential as a therapeutic agent for staph infections.
